Top compounds associated with response to INHBA


Feature Type Standardized
Nominal ANOVA
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.5
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA EX-527 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.03 0.5
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.031 0.5
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.5
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.024 0.5
mRNA QS11 CTRPv2 pan-cancer AAC -0.048 0.5
Download CSV